Challenge
The Austrian biotech group Novogenia has commissioned mrkt'in to develop a test strategy for the upcoming launch of a new personalized nutritional supplement.
Novogenia planned to introduce a new product in 2023 that focuses on individualized nutritional supplements as a subscription model. To guarantee the most successful product launch possible, the time leading up to the launch must be used to collect and analyze data to tailor an action plan with clear recommendations.
The following key questions arose for Novogenia:
Approach
We developed a testing approach addressing all those key questions and split it into 3 Phases:
Das sagt der Kunde